Todd Brady
Director/Board Member at CONTINEUM THERAPEUTICS, INC.
Profile
Todd R.
Brady is currently a Director at Vero Biotech LLC, Brace Pharmaceuticals, Inc., Vero Biotech, Inc., and Contineum Therapeutics, Inc. He previously held positions as a Director at Therabron Therapeutics, Inc., Avidity Biosciences, Inc., Tyrogenex, Inc., Cocrystal Pharma, Inc., and Interward Asset Management Ltd.
Mr. Brady completed his undergraduate degree at the University of Western Ontario and earned an MBA from The Schulich School of Business in 2007.
Todd Brady active positions
| Companies | Position | Start |
|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Director/Board Member | 2019-10-31 |
Vero Biotech LLC
 Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | Director/Board Member | - |
Brace Pharmaceuticals, Inc.
 Brace Pharmaceuticals, Inc. Investment ManagersFinance Brace Pharmaceuticals, Inc (Brace Pharmaceuticals) is a venture capital firm founded in 2013. The firm is headquartered in Atlanta. | Director of Finance/CFO | 2013-12-31 |
| Vero Biotech, Inc. | Director/Board Member | - |
Former positions of Todd Brady
| Companies | Position | End |
|---|---|---|
| AVIDITY BIOSCIENCES, INC. | Director/Board Member | 2021-01-10 |
| COCRYSTAL PHARMA, INC. | Director/Board Member | 2020-03-09 |
Interward Asset Management Ltd.
 Interward Asset Management Ltd. Investment ManagersFinance Interward Asset Management, Ltd. (IAM) is an investment advisor headquartered in Toronto, Ontario and was founded in 1990. IAM provides investment advice to institutional investors and individuals. They focus on opportunities in North American small and mid-capitalization companies. | Analyst-Equity | 2008-12-30 |
Therabron Therapeutics, Inc.
 Therabron Therapeutics, Inc. BiotechnologyHealth Technology Therabron Therapeutics, Inc. provides biotechnology services. It is focused on the advancement of respiratory therapeutics with disease-modifying potential. The company was founded by Aprile Pilon in 2007 and is headquartered in Rockville, MD. | Director/Board Member | - |
Tyrogenex, Inc.
 Tyrogenex, Inc. Pharmaceuticals: MajorHealth Technology Tyrogenex, Inc. operates as a biopharmaceutical company which develops dual vascular endothelial growth factor receptor and platelet-derived growth factor receptor inhibitors for wet age-related macular degeneration and solid tumors. Its compound targets the basic mechanisms of neovascular eye diseases, including angiogenesis, fibrosis and inflammation. The company was founded by Chris Liang, Teri Ardleigh Swift, and Sheridan G. Snyder and is headquartered in Rockville, MD. | Director/Board Member | - |
Training of Todd Brady
| University of Western Ontario | Undergraduate Degree |
| The Schulich School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| AVIDITY BIOSCIENCES, INC. | Health Technology |
| COCRYSTAL PHARMA, INC. | Health Technology |
| CONTINEUM THERAPEUTICS, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Vero Biotech LLC
Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | Health Technology |
Therabron Therapeutics, Inc.
Therabron Therapeutics, Inc. BiotechnologyHealth Technology Therabron Therapeutics, Inc. provides biotechnology services. It is focused on the advancement of respiratory therapeutics with disease-modifying potential. The company was founded by Aprile Pilon in 2007 and is headquartered in Rockville, MD. | Health Technology |
Interward Asset Management Ltd.
Interward Asset Management Ltd. Investment ManagersFinance Interward Asset Management, Ltd. (IAM) is an investment advisor headquartered in Toronto, Ontario and was founded in 1990. IAM provides investment advice to institutional investors and individuals. They focus on opportunities in North American small and mid-capitalization companies. | Finance |
Tyrogenex, Inc.
Tyrogenex, Inc. Pharmaceuticals: MajorHealth Technology Tyrogenex, Inc. operates as a biopharmaceutical company which develops dual vascular endothelial growth factor receptor and platelet-derived growth factor receptor inhibitors for wet age-related macular degeneration and solid tumors. Its compound targets the basic mechanisms of neovascular eye diseases, including angiogenesis, fibrosis and inflammation. The company was founded by Chris Liang, Teri Ardleigh Swift, and Sheridan G. Snyder and is headquartered in Rockville, MD. | Health Technology |
Brace Pharmaceuticals, Inc.
Brace Pharmaceuticals, Inc. Investment ManagersFinance Brace Pharmaceuticals, Inc (Brace Pharmaceuticals) is a venture capital firm founded in 2013. The firm is headquartered in Atlanta. | Finance |
| Vero Biotech, Inc. |
- Stock Market
- Insiders
- Todd Brady
